Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
TERBINAFINA ARENA 250 mg
Antifungal drug indicated in the treatment of cutaneous mycoses and onychomycosis (nail fungus)
Active Substance (INN)
TERBINAFINUM
Packaging
2 blisters x 14 tablets
Adverse Reaction Reporting
If you wish to report adverse reactions, please send us the completed adverse reaction reporting form.
Adverse Reaction Form
Read the instructions for use carefully! Consult a doctor or pharmacist to find out about the risks and side effects.